The Uyghur Forced Labor Prevention Act continues to affect medical supply importers, with Customs and Border Protection maintaining active enforcement against goods with any connection to Xinjiang-linked forced labor in the supply chain — a particular concern for medical textile products, given the region's significant role in global cotton production.
Why Medical Supply Faces Particular Exposure
Cotton-based medical textiles — gauze, some gown and drape materials, certain wound care products — draw directly on global cotton supply chains where Xinjiang-origin cotton has historically represented a meaningful share of total production, even when the finished product is manufactured and labeled from a different country entirely. That makes supply chain traceability considerably harder than a simple country-of-manufacture check would suggest.
What Enforcement Actually Looks Like
- CBP can detain shipments under a rebuttable presumption of forced labor connection, placing the burden of proof on the importer to demonstrate the supply chain is clean
- Documentation demands during a detention review are extensive, often requiring traceability evidence several tiers back into raw material sourcing that many importers struggle to produce quickly
- Detained shipments can face lengthy delays even when ultimately cleared, creating real supply continuity risk for facilities dependent on the affected product
What Buyers Should Ask Suppliers
Facility procurement teams working with distributors on cotton-based or other Xinjiang-supply-chain-adjacent products should ask directly what raw material traceability documentation the supplier maintains, and should treat a supplier's inability to answer clearly as a genuine supply continuity risk factor, not just a compliance technicality.
Facilities sourcing compliant textile products can review Healix Medical Supply's textiles catalog.
